欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2019/001
药品名称
Alluzience
活性成分
botulinum toxin 200.0 U/ml
剂型
Solution for injection
上市许可持有人
Ipsen Pharma France
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Italy (IT)
Romania (RO)
Germany (DE)
Alluzience
Greece (GR)
Slovakia (SK)
Denmark (DK)
Alluzience
Norway (NO)
Alluzience
Slovenia (SI)
Belgium (BE)
Alluzience 200 Speywood-eenheden/ml oplossing voor injectie
Finland (FI)
United Kingdom (Northern Ireland) (XI)
Netherlands (NL)
Poland (PL)
Alluzience
Luxembourg (LU)
Latvia (LV)
Alluzience 200 Speywood vienības/ml šķīdums injekcijām
Iceland (IS)
Alluzience
Malta (MT)
Alluzience, 200 U solution for injection
Lithuania (LT)
Alluzience 200 V/ml injekcinis tirpalas
Ireland (IE)
Croatia (HR)
Estonia (EE)
Austria (AT)
Alluzience 200 Speywood-Einheiten/ml Injektionslösung
Hungary (HU)
Alluzience (Solution for injection 200 U/ml)
France (FR)
Alluzience
Bulgaria (BG)
Alluzience
Spain (ES)
Cyprus (CY)
Alluzience 200U/ml solution for injection
Portugal (PT)
Czechia (CZ)
Alluzience
许可日期
2021/06/10
最近更新日期
2024/11/26
药物ATC编码
M03AX01 botulinum toxin
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Full Dossier Art 8.3(i) Dir 2001/83/EC
TypeLevel4:
Biological: Other
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
Alluzience_20solution_20for_20injection_20ENG_20PAR_09001bee81e74f7d_pdf
Date of last change:2024/09/06
PubAR Summary
|
Alluzience_20solution_20for_20injection_20ENG_20sPAR_09001bee81e74f80_pdf
Date of last change:2024/09/06
Final PL
|
SE_H_2019_001_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_2019_001_Final SPC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase